Reversal Agents

Managing Reversal Of Direct Oral Anticoagulants In Emergency Situations

A Prospective Cohort Study Of Idarucizumab For Reversal

Idarucizumab: The Antidote For Reversal Of Dabigatran

Videos Dabigatran Reversal Andexanet Alfa Ciraparantag Guidelines

Reversal Agents - New This Month

Specific antidotes for bleeding associated with direct oral anticoagulants

Burnett A, Siegal D, Crowther M, et al

BMJ 2017;357:j2216
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management

Alexander Niessner, Juan Tamargo, João Morais, et al

Eur Heart J (2017) 38 (22): 1710-1716.
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Charles V. Pollack, Paul A. Reilly, Joanne van Ryn, et al

Reversal Agents - Idarucizumab for Dabigatran Reversal

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial

Stephan Glund, J. Stangier, Michael Schmohl, et al

Lancet 2015; 386: 680–690.
A Prospective Cohort Study of Idarucizumab for Reversal of Dabigatran-Associated Hemorrhage

Robert M. Starke, Ricardo J Komotar, E. Sander Connolly, et al

Neurosurgery. 2015 Dec;77(6):N11-3.
Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects

Paul A. Reilly, J. van Ryn, Oliver Grottke, et al

Am J Med. 2016 Nov;129(11S):S64-S72.
Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

Milan R. Vosko, Christof Bocksrucker, Rafał Drwiła, et al

J Thromb Thrombolysis. 2017 Apr;43(3):306-317.

Reversal Agents - Andexanet Alfa for Factor Xa Inhibitors

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors

Mark Crowther, Mathur Vandana, Kitt Michael, et al

Blood 2013 122:3636;
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal of Edoxaban-Induced Anticoagulation in Healthy Subjects By Andexanet Alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors

Mark Crowther, Gallia G. Levy, Genmin Lu, et al

Blood 2014 124:4269;
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

Stuart J. Connolly, Truman J. Milling, John Eikelboom, et al

N Engl J Med. 2016 Sep 22;375(12):1131-41.

Reversal Agents - Ciraparantag for Factor Xa Inhibitors

Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin

Jack E. Ansell, Bryan E. Laulicht, Sasha H. Bakhru, et al

Thromb Res. 2016 Oct;146:113-118.
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban

Jack E. Ansell, Sasha H. Bakhru, Bryan E. Laulicht, et al

Thromb Haemost. 2017 Jan 26;117(2):238-245.

Reversal Agents - Guidelines/expert recommendations

Reversal of Direct Oral Anticoagulants: Current Status and Future Directions

Jeffrey I. Weitz

Semin Respir Crit Care Med. 2017 Feb;38(1):40-50.
Managing reversal of direct oral anticoagulants in emergency situations

Walter Ageno, Harry R. Buller, A. Falanga, et al

Thromb Haemost. 2016 Nov 30;116(6):1003-1010.
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH

Jerrold H. Levy, Walter Ageno, N. C. Chan, et al

J Thromb Haemost. 2016 Mar;14(3):623-7.
Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association

Amish N. Raval, Joaquin E. Cigarroa, Mina K. Chung, et al

Circulation. 2017;135:e604-e633

SPAF News

Death From Specific Causes Up for Veterans With PTSD

24 June 2019

MONDAY, June 24, 2019 -- Among veterans with posttraumatic stress disorder (PTSD), all-cause...
Older Americans Generally Current With Eye Exams

24 June 2019

MONDAY, June 24, 2019 -- Rates of eye examinations within the past two years are generally high...
Adrenal Incidentalomas Rarely Grow, Change Hormone Function

24 June 2019

MONDAY, June 24, 2019 -- Nonfunctioning adrenal tumors (NFATs) or adenomas causing mild autonomous...
Many Trust Doctors, Nurses Over Other Sources of Health Advice

24 June 2019

MONDAY, June 24, 2019 -- Globally, about three-quarters of people trust doctors or nurses more than...
Colonoscopy Quality Not Affected by Sedation Method

24 June 2019

MONDAY, June 24, 2019 -- Among patients at average risk undergoing screening colonoscopies, there...
Non-invasive view into the heart

24 June 2019

The non-invasive measurement of blood flow to the heart using magnetic resonance imaging (MRI) is...